RNAseq of mononuclear cells derived from peripheral blood or bone marrow of acute promyelocytic leukemia patients
The goal of this study was to investigate and identify potential factors deregulated in aute promyelocytic leukemia patients that suffer from an early death (APL-ED) upon all-trans retinoic acid (ATRA)- and arsenic trioxide (ATO)-based therapy compared to normal APL patients undergoing the same treatment.